Company A1M Pharma AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/18/01 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 14/20/14 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/22/01 |
Sara Thuresson
CTO | Chief Tech/Sci/R&D Officer | 48 | 24/21/24 |
Torbjörn Larsson
PRN | Corporate Officer/Principal | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 01/21/01 |
Göran Forsberg
BRD | Director/Board Member | 61 | 29/19/29 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 01/22/01 |
Lars Höckenström
BRD | Director/Board Member | 68 | 23/19/23 |
Johannes Hulthe
BRD | Director/Board Member | 54 | 29/19/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,061,615 | 7,464,712 ( 74.19 %) | 0 | 74.19 % |
Company contact information
Guard Therapeutics International AB
Nybrogatan 34 2nd Floor
114 39, Stockholm
+46 86 70 65 51
http://www.guardtherapeutics.com![address A1M Pharma AB](https://cdn.zonebourse.com/static/address/34972723.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 3.91TCr | |
-8.62% | 3.88TCr | |
+26.95% | 3.12TCr | |
+10.74% | 2.59TCr | |
-13.50% | 2.58TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.31TCr | |
-7.14% | 1.13TCr | |
-12.61% | 1.07TCr |
- Stock Market
- Equities
- GUARD Stock
- Stock
- Company A1M Pharma AB